Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 8816750.
- Also identified by PMC identifier 38335.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have previously shown that the G protein of vesicular stomatitis virus (VSV-G) can be incorporated into the virions of retroviruses. Since expression of VSV-G is toxic to most mammalian cells, development of stable VSV-G packaging cell lines requires inducible VSV-G expression. We have modified the tetracycline-inducible system by fusing the ligand binding domain of the estrogen receptor to the carboxy terminus of a tetracycline-regulated transactivator. Using this system, we show that VSV-G expression is tetracycline-dependent and can be modulated by beta-estradiol. Stable packaging cell lines can readily be established and high-titer pseudotyped retroviral vectors can be generated upon induction of VSV-G expression.
Medical subject headings
- Estradiol
- Genetic Vectors
- Membrane Glycoproteins
- Receptors, Estrogen
- Recombinant Fusion Proteins
- Retroviridae
- Tetracycline
- Trans-Activators
- Vesicular stomatitis Indiana virus
- Viral Envelope Proteins